HOUSTON, Nov. 24, 2025 /PRNewswire/ — PathKeeper Surgical, a leader in AI-driven optical navigation, announced a pivotal milestone. Renowned Houston spine surgeon, Dr. Richard Westmark, has successfully performed the first outpatient spine procedure at an Ambulatory Surgery Center (ASC) utilizing the company’s revolutionary technology.
The PathKeeper system is unique employing proprietary AI and ultra-high resolution 3D cameras to provide real-time surgical guidance. This eliminates the need for traditional radiation heavy intraoperative CT, delivering a crucial safety advantage. The system delivers verified sub-millimetric accuracy for registration and instrument tracking.
This successful adoption underscores Pathkeeper’s unique qualification in the ASC market, a segment requiring highly efficient, low-footprint, and cost-effective enabling technology.
In commenting on the milestone, Dr. Richard Westmark stated: “The ability to perform navigation guided spine surgery in an outpatient setting without exposing my patients or my team to ionizing radiation is a paradigm shift. PathKeeper is a powerful tool that can be utilized in the ASC to potentially improve the safety and efficacy of spine surgery by giving us the highest level of accuracy while streamlining workflow. PathKeeper elevates the standard of care we can deliver in the ASC.”
About PathKeeper:
PathKeeper Surgical, an Israeli MedTech company, dedicated to improving spine and orthopedic surgical intervention using AI and specialized optics. Their core mission is to make navigation-guided surgery accessible in any operating room. The company continues its commitment to bringing next-generation, value-based enabling tech solutions worldwide.
Contact:
Ryan LeBlanc, Chief Commercial Officer
RYAN.LEBLANC@path-keeper.com
www.path-keeper.com
Photo: https://healthtechnologynet.com/wp-content/uploads/2025/11/Surgical_case_USPI_ASC.jpg
SOURCE PathKeeper
Registration Link for Phio's Presentation on Thursday, January 22 at 1:45 PM ETKing of Prussia,…
WASHINGTON, D.C. / ACCESS Newswire / January 15, 2026 / The American Medical Informatics Association…
CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody; binds to unique CD38 epitopeAMR is a…
Multi-year wins underscore sustained specialty-first innovation, workflow depth, and revenue-cycle performance at scale TAMPA, FLORIDA…
First of its kind in the UK as medical cannabis patients get on-demand legal support…
NOTTINGHAM, UK / ACCESS Newswire / January 15, 2026 / First of its kind in…